118 related articles for article (PubMed ID: 19046249)
1. Changes in transferrin are related to changes in insulin resistance: the SLIM study.
Roumen C; Feskens EJ; Jansen EH; Saris WH; Blaak EE
Diabet Med; 2008 Dec; 25(12):1478-82. PubMed ID: 19046249
[TBL] [Abstract][Full Text] [Related]
2. Impact of 3-year lifestyle intervention on postprandial glucose metabolism: the SLIM study.
Roumen C; Corpeleijn E; Feskens EJ; Mensink M; Saris WH; Blaak EE
Diabet Med; 2008 May; 25(5):597-605. PubMed ID: 18445174
[TBL] [Abstract][Full Text] [Related]
3. Ferritin and transferrin are both predictive of the onset of hyperglycemia in men and women over 3 years: the data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study.
Fumeron F; Péan F; Driss F; Balkau B; Tichet J; Marre M; Grandchamp B;
Diabetes Care; 2006 Sep; 29(9):2090-4. PubMed ID: 16936158
[TBL] [Abstract][Full Text] [Related]
4. [Anemia and iron metabolism in patients with type-2 diabetes mellitus].
Kovács F; Szakál I; Révész K; Lévai A; Dobos A
Orv Hetil; 2006 Feb; 147(8):345-9. PubMed ID: 16579333
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers of iron metabolism are independently associated with impaired glucose metabolism and type 2 diabetes: the KORA F4 study.
Huth C; Beuerle S; Zierer A; Heier M; Herder C; Kaiser T; Koenig W; Kronenberg F; Oexle K; Rathmann W; Roden M; Schwab S; Seissler J; Stöckl D; Meisinger C; Peters A; Thorand B
Eur J Endocrinol; 2015 Nov; 173(5):643-53. PubMed ID: 26294793
[TBL] [Abstract][Full Text] [Related]
6. Iron metabolism is prospectively associated with insulin resistance and glucose intolerance over a 7-year follow-up period: the CODAM study.
Wlazlo N; van Greevenbroek MM; Ferreira I; Jansen EH; Feskens EJ; van der Kallen CJ; Schalkwijk CG; Bravenboer B; Stehouwer CD
Acta Diabetol; 2015 Apr; 52(2):337-48. PubMed ID: 25267079
[TBL] [Abstract][Full Text] [Related]
7. Transferrin and iron induce insulin resistance of glucose transport in adipocytes.
Green A; Basile R; Rumberger JM
Metabolism; 2006 Aug; 55(8):1042-5. PubMed ID: 16839839
[TBL] [Abstract][Full Text] [Related]
8. Iron-binding antioxidant capacity is impaired in diabetes mellitus.
Van Campenhout A; Van Campenhout C; Lagrou AR; Moorkens G; De Block C; Manuel-y-Keenoy B
Free Radic Biol Med; 2006 May; 40(10):1749-55. PubMed ID: 16678014
[TBL] [Abstract][Full Text] [Related]
9. Addition of n-3 fatty acids to a 4-hour lipid infusion does not affect insulin sensitivity, insulin secretion, or markers of oxidative stress in subjects with type 2 diabetes mellitus.
Mostad IL; Bjerve KS; Basu S; Sutton P; Frayn KN; Grill V
Metabolism; 2009 Dec; 58(12):1753-61. PubMed ID: 19716144
[TBL] [Abstract][Full Text] [Related]
10. Alteration in iron metabolism during retinal degeneration in rd10 mouse.
Deleon E; Lederman M; Berenstein E; Meir T; Chevion M; Chowers I
Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1360-5. PubMed ID: 18997094
[TBL] [Abstract][Full Text] [Related]
11. [The evaluation of iron exchange parameters in patients with coronary atherosclerosis and type 2 diabetes mellitus].
Gorokhova SG; Atamanova MA; Muraseeva EV
Klin Med (Mosk); 2007; 85(11):50-4. PubMed ID: 18219957
[TBL] [Abstract][Full Text] [Related]
12. Lymphocyte labile iron pool, plasma iron, transferrin saturation and ferritin levels in colon cancer patients.
Gackowski D; Kruszewsk M; Banaszkiewicz Z; Jawien A; Olinski R
Acta Biochim Pol; 2002; 49(1):269-72. PubMed ID: 12136950
[TBL] [Abstract][Full Text] [Related]
13. Association of iron indices and type 2 diabetes: a meta-analysis of observational studies.
Orban E; Schwab S; Thorand B; Huth C
Diabetes Metab Res Rev; 2014 Jul; 30(5):372-94. PubMed ID: 24327370
[TBL] [Abstract][Full Text] [Related]
14. Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response.
Rijkelijkhuizen JM; Doesburg T; Girman CJ; Mari A; Rhodes T; Gastaldelli A; Nijpels G; Dekker JM
Metabolism; 2009 Feb; 58(2):196-203. PubMed ID: 19154952
[TBL] [Abstract][Full Text] [Related]
15. Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors.
St George A; Bauman A; Johnston A; Farrell G; Chey T; George J
J Gastroenterol Hepatol; 2009 Mar; 24(3):399-407. PubMed ID: 19067776
[TBL] [Abstract][Full Text] [Related]
16. Dysfunction of the retinal pigment epithelium with age: increased iron decreases phagocytosis and lysosomal activity.
Chen H; Lukas TJ; Du N; Suyeoka G; Neufeld AH
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1895-902. PubMed ID: 19151392
[TBL] [Abstract][Full Text] [Related]
17. Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: Implications of diabetes mellitus.
Jaumdally RJ; Lip GY; Patel JV; MacFadyen RJ; Varma C
J Intern Med; 2009 Jun; 265(6):689-97. PubMed ID: 19226374
[TBL] [Abstract][Full Text] [Related]
18. Elevated levels of ferritin and hs-CRP in type 2 diabetes.
Alam F; Fatima F; Orakzai S; Iqbal N; Fatima SS
J Pak Med Assoc; 2014 Dec; 64(12):1389-91. PubMed ID: 25842584
[TBL] [Abstract][Full Text] [Related]
19. Ovariectomy and estrogen treatment modulate iron metabolism in rat adipose tissue.
Mattace Raso G; Irace C; Esposito E; Maffettone C; Iacono A; Di Pascale A; Santamaria R; Colonna A; Meli R
Biochem Pharmacol; 2009 Oct; 78(8):1001-7. PubMed ID: 19501056
[TBL] [Abstract][Full Text] [Related]
20. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men.
Nagpal J; Pande JN; Bhartia A
Diabet Med; 2009 Jan; 26(1):19-27. PubMed ID: 19125756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
